AwardedPOLGoods
Dostawa leków stosowanych w programach lekowych.
- Published
- Published 23 February 2026
- Deadline
- Closed 30 March 2026
Overview
Centrum Onkologii Ziemi Lubelskiej im. św. Jana z Dukli procured pharmaceutical supplies for drug programs, divided into four lots covering Rucaparib, Pasireotide, Axicabtagene ciloleucel, and Brexucabtagen autoleucel. The contract was awarded on 6 June 2026 to Gilead Sciences Poland Sp. z o.o., Neuca S.A., and Urtica Sp. z o.o. for a total value of 30,913,138.35 PLN.
Key details
- Country
- POL
- Status
- Awarded
- Category
- Goods
- Procedure
- Open
- Published
- 23 February 2026
- Deadline
- Closed
Various medicinal products
Award outcome
- Awarded value
- PLN 30,913,138
- Award date
- 7 June 2026
- Contract period
- — → 14 July 2027
- Gilead Sciences Poland Sp. z o.o.
- Neuca S.A.
- Urtica Sp. z o.o.
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
2 July 2026
Contract Notice
23 February 2026
Contracting authority
Centrum Onkologii Ziemi Lubelskiej im. św. Jana z Dukli
Procuring entityLublin, POL
Authority website ↗
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.